Figure 4.
Platelet aggregation is not affected by treatment with iMer in the absence of GAS6. Human PRP was treated with antibody to deplete GAS6 and then incubated with 5 μM iMer (red) or vehicle control (green) before platelet activation was stimulated with 1 to 2 mM ADP. Median values and error bars denoting IQR from 3 experiments are shown (P = ns, Wilcoxon signed pairs rank test).

Platelet aggregation is not affected by treatment with iMer in the absence of GAS6. Human PRP was treated with antibody to deplete GAS6 and then incubated with 5 μM iMer (red) or vehicle control (green) before platelet activation was stimulated with 1 to 2 mM ADP. Median values and error bars denoting IQR from 3 experiments are shown (P = ns, Wilcoxon signed pairs rank test).

or Create an Account

Close Modal
Close Modal